ES536055A0 - Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii - Google Patents

Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii

Info

Publication number
ES536055A0
ES536055A0 ES536055A ES536055A ES536055A0 ES 536055 A0 ES536055 A0 ES 536055A0 ES 536055 A ES536055 A ES 536055A ES 536055 A ES536055 A ES 536055A ES 536055 A0 ES536055 A0 ES 536055A0
Authority
ES
Spain
Prior art keywords
iii complex
antithrombine
procedure
production
covalently linked
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES536055A
Other languages
English (en)
Other versions
ES8604623A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Publication of ES8604623A1 publication Critical patent/ES8604623A1/es
Publication of ES536055A0 publication Critical patent/ES536055A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ES536055A 1983-09-26 1984-09-19 Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii Expired ES8604623A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/536,072 US4689323A (en) 1983-09-26 1983-09-26 Covalently bound heparin--antithrombin-III complex

Publications (2)

Publication Number Publication Date
ES8604623A1 ES8604623A1 (es) 1986-02-01
ES536055A0 true ES536055A0 (es) 1986-02-01

Family

ID=24137020

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536055A Expired ES8604623A1 (es) 1983-09-26 1984-09-19 Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii

Country Status (7)

Country Link
US (1) US4689323A (es)
EP (1) EP0137356B1 (es)
AT (1) ATE44156T1 (es)
AU (1) AU573262B2 (es)
CA (1) CA1240264A (es)
DE (1) DE3478749D1 (es)
ES (1) ES8604623A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
DK148890D0 (da) * 1990-06-19 1990-06-19 Novo Nordisk As Farmaceutisk praeparat
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US6491965B1 (en) * 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
AT405905B (de) * 1997-03-25 1999-12-27 Immuno Ag Neue verwendung von antithrombin iii
JP3096737B1 (ja) * 1999-07-19 2000-10-10 工業技術院長 ヒト・動物細胞培養液
ATE377657T1 (de) * 2001-01-26 2007-11-15 Gen Hospital Corp Serpin-arzneistoffe zur behandlung einer hiv- infektion und verfahren zu deren verwendung
US8563693B2 (en) * 2001-01-26 2013-10-22 Acceleration Biopharmaceuticals, Inc. Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III
WO2021201950A1 (en) * 2020-04-04 2021-10-07 The Board Of Regents Of The University Of Texas System Method for reducing the occurrence of thrombosis or thromboembolism

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301153A (en) * 1977-03-21 1981-11-17 Riker Laboratories, Inc. Heparin preparation
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
US4446126A (en) * 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Antithrombin-heparin complex and method for its production
ATE12779T1 (de) * 1980-09-30 1985-05-15 Bayer Ag Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
DE3038163A1 (de) * 1980-10-09 1982-05-06 Boehringer Mannheim Gmbh, 6800 Mannheim Thrombininhibitor, seine herstellung und verwendung

Also Published As

Publication number Publication date
EP0137356A2 (en) 1985-04-17
ES8604623A1 (es) 1986-02-01
AU3356884A (en) 1985-04-04
US4689323A (en) 1987-08-25
DE3478749D1 (en) 1989-07-27
EP0137356A3 (en) 1986-05-14
AU573262B2 (en) 1988-06-02
CA1240264A (en) 1988-08-09
EP0137356B1 (en) 1989-06-21
ATE44156T1 (de) 1989-07-15

Similar Documents

Publication Publication Date Title
ES538807A0 (es) Un procedimiento para la produccion de un complejo covalentemente unido de inhibidor de alfa-1-proteinasas con un polimero soluble en agua.
ES536055A0 (es) Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii
DE3268075D1 (en) Preparation for treating outer skin wounds and process for manufacturing said preparation
PH23867A (en) Method of treating parkinson's disease using indolone derivatives
GEP20084347B (en) New derivatives of diphosphonic acid, method for their preparation and medicamentous form containing them
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
HUT62798A (en) Process for producing pharmaceutical composition with slimming activity
HUT58520A (en) Process for producing pharmaceutical composition suitable for treating impotence
EP0350036A3 (en) Topical hematoporphyrin
BE898749A (fr) Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic
GB8824869D0 (en) Synthetic antibody
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
EP0285856A3 (en) Use of dihydroergotamine and its salts in the local treatment of trophic disorders
AU5198693A (en) A method of increasing adenosine excretion
HK1004485A1 (en) Compositions and methods using unbound mpl receptor for stimulating platelet production
EP0441395A3 (en) Human monoclonal antibody and pharmaceutical composition containing the same for the treatment of pseudomonas infections
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
HUT57597A (en) Process for producing pharmaceutical composition
PT80214A (en) Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon
DE3470002D1 (en) Use of l-fucose in the preparation of an inhalation composition and a process for preparing l-fucose
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
SU1263246A1 (ru) Способ лечени острого стоматита
AT389114B (de) 7-acyloxy-6-aminoacyloxypolyoxylabdane und verfahren zu ihrer herstellung
HU213268B (en) Process for producing pharmaceutical composition for treating dermatological diseases
GB9106663D0 (en) Detoxification using micro-organisms

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20051110